Evidence map›Paper›PMID 33941686›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Protein structure-based gene expression signatures.

Rayees Rahman, Nicole Zatorski, Jens Hansen, Yuguang Xiong, J G Coen van Hasselt, Eric A Sobie, Marc R Birtwistle, Evren U Azeloglu, Ravi Iyengar, Avner Schlessinger

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rayees RahmanDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; rayees.rahman@icahn.mssm.edu ravi.iyengar@mssm.edu avner.schlessinger@mssm.edu.ORCID 0000-0002-0248-0680
Nicole ZatorskiDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-5697-4056
Jens HansenDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0002-1362-6534
Yuguang XiongDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-5221-6266
J G Coen van HasseltDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0002-1664-7314
Eric A SobieDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Marc R BirtwistleDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0002-0341-0705
Evren U AzelogluDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-6137-109X
Ravi IyengarDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; rayees.rahman@icahn.mssm.edu ravi.iyengar@mssm.edu avner.schlessinger@mssm.edu.ORCID 0000-0002-7814-0180
Avner SchlessingerDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; rayees.rahman@icahn.mssm.edu ravi.iyengar@mssm.edu avner.schlessinger@mssm.edu.ORCID 0000-0003-4007-7814

Funding

Drug Combination Signatures for Prediction and Mitigation of ToxicityU54HG008098 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIRTWISTLE, MARC R., BIRTWISTLE, MARC R. · 2014 to 2019
$11.8M
Teaching biomedical and pharmacological trainees to produce FAIR data for AI & ML applicationsT32GM062754 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHLESSINGER, AVNER · 2001 to 2023
$6.2M
Substrate Specificity Determinants in Nutrient Solute Carrier TransportersR01GM108911 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHLESSINGER, AVNER · 2014 to 2022
$3.1M
Systems Pharmacology for overcoming cell variabilityR01GM137056 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IYENGAR, SRINIVAS RAVI V · 2020 to 2023
$1.9M
NHGRI NIH HHS U54 HG008098NIGMS NIH HHS R01 GM108911NIGMS NIH HHS R01 GM137056NIGMS NIH HHS T32 GM062754
6 · The paper itself

Abstract

Gene expression signatures (GES) connect phenotypes to differential messenger RNA (mRNA) expression of genes, providing a powerful approach to define cellular identity, function, and the effects of perturbations. The use of GES has suffered from vague assessment criteria and limited reproducibility. Because the structure of proteins defines the functional capability of genes, we hypothesized that enrichment of structural features could be a generalizable representation of gene sets. We derive structural gene expression signatures (sGES) using features from multiple levels of protein structure (e.g., domain and fold) encoded by the mRNAs in GES. Comprehensive analyses of data from the Genotype-Tissue Expression Project (GTEx), the all RNA-seq and ChIP-seq sample and signature search (ARCHS4) database, and mRNA expression of drug effects on cardiomyocytes show that sGES are useful for characterizing biological phenomena. sGES enable phenotypic characterization across experimental platforms, facilitates interoperability of expression datasets, and describe drug action on cells.

Indexed as

Protein ConformationTranscriptomeCell LineChromatin Immunoprecipitation SequencingComputational BiologyGene ExpressionGene Expression ProfilingHumansMyocytes, CardiacProteinsReproducibility of ResultsRNA, MessengerRNA-SeqProteinsRNA, Messengergene expression signaturesreproducibilitystructural bioinformatics

Identifiers

PMID33941686
PMCPMC8126868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.